Science Explorer Interactive view Map
Company · Berlin · Germany

JPT Peptide Technologies (Germany)

jpt.comROR OpenAlex
Research works
58
▼ 37% vs 2013–17
Citations
2k
33.6 per fractional work
Top-10% rate
18.9%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: JPT Peptide Technologies (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.43× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 15.80× its world share, 1 worksImmunology and Micro…Neuroscience: 0.87× its world share, 0 worksNeuroscienceChemistry: 2.63× its world share, 0 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceMaterials Science: 0.54× its world share, 0 worksMaterials ScienceMedicine: 2.38× its world share, 3 worksMedicineSocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.8×. Every wedge is a field page.

Which keywords describe research at JPT Peptide Technologies (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Drug Discovery, Innate Immunity and Antigen Presentation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation8▲ 62×3 topics
  2. Monoclonal Antibodies6▲ 77×2 topics
  3. Therapeutic Antibodies6▲ 86×2 topics
  4. Antibody Engineering6▲ 107×1 topic
  5. Fc Receptors6▲ 107×1 topic
  6. Drug Discovery5▲ 23×6 topics
  7. Inflammation4▲ 3.3×13 topics
  8. Innate Immunity4▲ 22×6 topics
  9. Antigen Presentation4▲ 62×2 topics
  10. Cancer4▲ 4.4×11 topics
  11. Foldamers3▲ 73×1 topic
  12. Mass Spectrometry3▲ 28×3 topics
  13. Peptide Synthesis3▲ 73×1 topic
  14. High-Throughput Analysis3▲ 120×1 topic
  15. Protein Microarrays3▲ 277×1 topic
  16. Proteomics3▲ 44×3 topics
  17. Immunity3▲ 15×4 topics
  18. Immune Response2▲ 7.0×10 topics
  19. Cancer Therapy2▲ 5.9×8 topics
  20. Cancer Immunotherapy2▲ 25×2 topics
  21. Epitope Prediction2▲ 193×1 topic
  22. Peptide-MHC Binding2▲ 193×1 topic
  23. Antioxidant Activity2▲ 6.1×4 topics
  24. Immune Modulation2▲ 25×2 topics
  25. Bioactive Compounds2▲ 17×2 topics
  26. Protein Identification2▲ 130×1 topic
  27. Quantitative Analysis2▲ 19×1 topic
  28. Counter-Current Chromatography2▲ 161×1 topic
  29. Glycans2▲ 36×1 topic
  30. Immune System2▲ 9.0×1 topic
  31. Natural Product Isolation2▲ 161×1 topic
  32. Angiogenesis2▲ 6.7×5 topics
  33. Neurodegeneration2▲ 8.5×3 topics
  34. Vaccine2▲ 6.8×7 topics
  35. Dendritic Cells2▲ 23×1 topic
  36. Host Defense2▲ 40×2 topics
  37. Tumor Antigen2▲ 32×1 topic
  38. Metastasis1▲ 7.2×3 topics
  39. SARS-CoV-21▲ 16×3 topics
  40. Tumor Microenvironment1▲ 7.0×5 topics

Which research topics does JPT Peptide Technologies (Germany) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis and vaccines and immunoinformatics approaches.

SARS-CoV-2 and COVID-19 Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksChemical Synthesis and A…0Chemical Synthesis and Analysis: 0 fractional worksvaccines and immunoinfor…0vaccines and immunoinformatics approaches: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksBeetle Biology and Toxicology Studies: 0 fractional worksAntimicrobial Peptides and Activities: 0 fractional works
Infectious DiseasesRadiology, Nuclear Medicine and ImagingMolecular BiologyImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Chemical Synthesis and Analysis Molecular Biology 0 works
  4. 4 vaccines and immunoinformatics approaches Molecular Biology 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 T-cell and B-cell Immunology Immunology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  9. 9 Beetle Biology and Toxicology Studies Cancer Research 0 works
  10. 10 Antimicrobial Peptides and Activities Microbiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.9%not open67.1%

World: 28% of research is openly available.

with international co-authors43.3%domestic only56.7%

World: 19% is written across borders.

How has JPT Peptide Technologies (Germany)'s research output changed?

Output in 2018–2022 was 37% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.